Shanghai Putuo District Recycling Whitening Agent Expired Rubber Additive Recycling

Whitening agent was recovered from Putuo District, Shanghai. In addition, according to the accounting standards, when the initial cost of China Coal Huajin is less than the share of the identifiable fair value of the company, the long-term equity cost is also included in the non operating income of 164 million yuan and the profit of 164 million yuan. Previously, an industry analyst told that the profits of coal chemical enterprises were mainly made by the price of chemicals in the middle reaches, and this trend began in early 2017. There were 20 construction accidents, up 53.8% year on year, including 5 major accidents, up 150% year on year—— "Three violations" accidents are frequent. 89.5% of accidents were caused by operation, violation of labor discipline, violation of operating procedures, among which 10.6% were caused by defects in equipment and facilities, unreasonable design, etc. From the perspective of supply, the accumulation of production and inventory is unfavorable to the rise of synthetic rubber price. 2. From the demand side, a. The operating rate of downstream tire enterprises is low, and the synthetic rubber is mainly purchased on demand. Data shows that on August 17, the operating rate of all steel tires was 67.37%, down 6.17% year on year; The operating rate of semi steel tires continued to fall 1.76% to 67.07%.

With the recovery of domestic and imported chemical raw materials, the company has strong financial strength and business staff all over the country. Recovering cobalt carbonate, lithium carbonate, cobalt sulfate, calcium carbonate, cobalt hydroxide, potassium dichromate, potassium carbonate, nickel, potassium stannate, potassium bromate, nickel mesh, potassium tungstate, potassium iodate, cuprous chloride, copper carbonate, basic copper carbonate, sodium tungstate, barium molybdate, nickel acetate, bismuth oxide, antimony trioxide, molybdenum oxide, cobalt neodecanoate, cobalt borate, cobalt boride, etc. Our company collects various chemical raw materials such as obsolete dyes, pigments, resins, paints, rubber, inks, additives, solvents, chemical reagents, etc.

The company seeks common development between enterprises and customers, and sincerely cooperates to build a better future with the business philosophy of environmental protection, speed and integrity.

Recycled dyes: disperse dyes, vat dyes, sulfur dyes, direct dyes, acid dyes, reactive dyes, basic dyes, cationic dyes, metal complex dyes, ice dyes.

Recycled pigments: gold powder, silver powder, aluminum silver paste, pearlescent powder, color paste, lithopone, titanium and fluorescent pigments of Yonggu, phthalocyanine, light resistant, Lisol, medium chromium, lake, chromogen, iron oxide and other series.

Recycled resins: epoxy resin, resin, alkyd resin, phenolic resin, polyurethane resin, unsaturated polyester resin, furan resin, petroleum resin, coumarone resin, polystyrene resin, ion exchange resin, rosin resin, etc.

Recycled rubber: natural rubber, synthetic rubber, chloroprene rubber, butyl rubber, styrene butadiene rubber, nitrile butadiene rubber, cis-1,4-polybutadiene rubber, and various rubber additives.

Recycle various auxiliaries: antioxidant, accelerator, flame retardant, anti scorching agent, leveling agent, surfactant, plasticizer, emulsifier, curing agent, colorant, fixing agent, etc.

Recycling of chemical raw materials and chemical reagents: various leather and fur auxiliaries, textile printing and dyeing auxiliaries, cobalt oxide, copper oxide, cuprous oxide, copper chloride, cuprous oxide, nickel sulfate, copper sulfate, and silver, potassium carbonate, and potassium iodide recovered from expired rubber auxiliaries of Shanghai Putuo District. Recycle all kinds of rubber, plastic raw materials, polyethylene glycol, resorcinol, hydroquinone, DMF, MDI., silicone oil, silicone oil, white mineral oil, heat transfer oil, hydraulic oil, waste engine oil, elastomer, zinc oxide, powder, stearic acid, zinc stearate, barium stearate, lead stearate, polyisobutene, wax PE wax, paraffin, chlorinated paraffin, recovered rosin, rosin resin, rosin glyceride, poly, polypropylene, PVC resin, S/thermoplastic elastomer, poly
, fumaric acid, oxalic acid, boric acid, citric acid, pectin, guar gum, xanthan gum, pressure sensitive adhesive, emulsion, water-based emulsion, sodium alginate, zinc ingot, red lead, yellow lead, vaseline, menthol, bisphenol A, maleic anhydride, phthalic anhydride, polyether, white carbon black. Recycle offset printing ink, plastic ink and surface printing ink. You, I buy, cash transaction, unlimited quantity, welcome your call. China is really on fire. On February 26 this year, the Outline of China's Strategic Plan for Development (2016-2030) (hereinafter referred to as the Outline) was officially released. The Outline points out that by 2020, the total output value of the Chinese medicine industry will account for more than 30% of the total industrial output value, and the Chinese industry will become one of the important pillars of the national economy, and "Chinese medicine health care services" will be listed as one of the seven major aspects of the national economy. Investors have already reached out to China, and some Chinese enterprises have been acquired with a valuation of nearly 10 billion yuan. In such a hot market, every Chinese medicine enterprise can be said to be in high spirits. Product upgrading, innovation, and capital borrowing are all available. There is no doubt that everyone will be honored! Driving the prosperity of pharmacy terminals may be just around the corner! For Chinese medicine enterprises, the Outline is undoubtedly a strong reassurance. For a long time, there have been different voices in the industry, arguing about the effectiveness and invalidity of traditional Chinese medicine. Wang Hongfeng, the chairman of Guizhou Liansheng Co., Ltd., pointed out that the current Outline has determined the gender status of China, and there is no need to debate the issue of effectiveness and invalidity. At the same time, the issue of the development path of China has been resolved. China's enterprises and competent departments are in the same place, which can help China's development avoid detours and mistakes. In addition, it is more important to mention such a strategic height, which covers three five-year plans, giving confidence to the Chinese industry, which plays a great role in the R&D investment of Chinese medicine enterprises. "In the past, because of the uncertainty of the future direction of the market, enterprises did not dare to make too much investment. Now the direction is clear, the industry people have confidence in Chinese medicine, capital will also enter, and the development of the industry will speed up." Wang Hongfeng said. In fact, capital is good for the market. In recent years, Jinben has invested more and more in China, and even Chinese enterprises have been acquired with a valuation of nearly 10 billion yuan. It is understood that Liansheng has also completed Round A, which is funded by three institutions. Wang Hongfeng said, "In addition to attracting funds, we also need to consider other resource advantages when choosing investment institutions. For example, among our institutions in Round A, one is venture capital in Guizhou Province, which is conducive to resource docking; the other is a large group with more than 4 billion yuan, which has rich resources in terms of resources." In addition, Liansheng, which has just completed Round A, will soon start Round B. It is understood that at present, there are more than a dozen companies with clear investment intentions. "We will select two or three of them to cooperate, not only for money, but also for wisdom and resources," said Wang Hongfeng. It is not difficult to see that the competition between capital and China has become quite fierce. If the policy and market are inclined to the center at the same time, will China's flowers bloom in the spring. The health care industry of traditional Chinese medicine is everywhere. "If the whole health industry is calculated based on 8 trillion yuan, the traditional Chinese medicine industry accounts for 30% of the total health industry, which is 2.4 trillion yuan. According to this algorithm, the traditional Chinese medicine industry will reach more than 3 trillion yuan in the next ten years." Wang Hongfeng also pointed out that the entire traditional Chinese medicine industry urgently needs to start from three aspects: industrial layout, product upgrading and service level upgrading, "After the upgrade, more and more people believe in Chinese medicine, and the scale of the industry can be expanded." This belongs to the long-term development plan of the Chinese medicine industry. What breakthrough does the industry have in the short term? Wang Hongfeng believes that each enterprise will have different breakthrough points according to its own technology and resource advantages. "Yunnan Baiyao has made a breakthrough in toothpaste by innovating in herbal tea, while we have made a breakthrough in traditional Chinese medicine. In the future, the breakthrough points of each enterprise will certainly be different, and a hundred flowers will blossom.
”According to relevant data, from 2011 to 2014, the output value of the domestic traditional Chinese medicine industry increased from 53 billion yuan to 680 billion yuan (including 102 billion yuan for the processing of traditional Chinese medicine decoction pieces). It is estimated that in 2015, the output value of traditional Chinese medicine will account for 25.7% of the total industrial output value, the total output value will be 720 billion yuan, and the processing of traditional Chinese medicine decoction pieces will reach 120 billion yuan. In the problem, the excavator will not be able to maintain health even though traditional Chinese medicine is everywhere, but there are still many problems. For example, on Chinese herbal pieces, there are problems such as whether the raw materials are effective and whether the packaging of finished products meets the market demand. Packaging is a problem that is easy to be ignored. When you think about it, the shop assistants seldom recommend Chinese herbal pieces to customers who enter the store. They are more accustomed to recommending various kinds of products at home and abroad. Apart from the profit commission, the product has more targeted functions, is easy to use, and the packaging is eye-catching and easy to be accepted by customers. In contrast, traditional Chinese medicine products do not seem to be so "fashionable". For example, a Xia Sangju granule has been sold for so many years, but it is almost the same technology and packaging. It has a poor sense of the times and is not attractive to the main consumers of the new generation. This is an era when the aroma of wine is also afraid of the depth of alleys. To put it bluntly, the "face value" of products is very important. Take Xia Sangju as an example. After customers buy it, few people will have a prominent and easy to get position like ordinary products at home. Most of them are in drawers. Among them, packaging is an unavoidable reason. Some research shows that the storage of products by customers directly affects the use of products, and the use rate of products is low, so will the purchase. Liansheng is very good at product packaging. Their Lianshengtang Broken Wall Slices invited a good domestic design company, Rococo, to design product packaging for them, and let the products speak for themselves, The positioning of Chinese medicine products, especially Chinese medicine decoction pieces, to target customers is too general, almost relying on a heat clearing and fire dispelling strategy to fight the world, and the products with expansion and relevance are not enough. Most of the time, consumers are not clear about the functions of the purchased Chinese medicine products, and even sometimes the shop assistants are wrong about the products. This has resulted in a waste of consumer demand, which has not yet explored the market potential. In this regard, Liansheng adheres to the concept of "prevention is more important than", employs good Chinese medicine and prescription science in China, and according to the thought of "syndrome differentiation and treatment" in, it has launched nine chronic disease programs, that is, Lianshengtang broken wall decoction pieces form small groups, and the people's demand for "prevention of disease". For example, "Sanqi broken wall decoction pieces" and "American ginseng broken wall decoction pieces" can regulate both qi and blood to prevent stroke and care for mental and brain health, "Kudzu broken wall decoction pieces", "Gastrodia elata broken wall decoction pieces" cervical spondylosis, relieve neck pain, stiffness, and "Liquorice broken wall decoction pieces" and "Chenpi broken wall decoction pieces" can reduce phlegm. The targeted chronic disease scheme developed by Liansheng through the research is effective and effective. At present, the market has received good feedback and achieved good results. "In order to solve the current problems in the industry, we have made our products have four attributes, namely,, convenient and cheap, which is why we can quickly market." In the future, the development space of the Chinese market is still very large. How to cooperate with industry and commerce in this market. Wang Hongfeng hit the nail on the head: "People don't go to the drugstore to buy medicine, but the ultimate goal is to solve common diseases and sub-health problems. Whether it is industry or terminal, they will develop in the direction of health solutions output. Who can solve problems for customers will win the market.